Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00324623
Status:
COMPLETED
Last Update Posted:
2012-11-20
First Post:
2006-05-10
Brief Title:
Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma
Sponsor:
Prof Serge Leyvraz
Organization:
Centre Hospitalier Universitaire Vaudois
Organization Data
Organization:
Centre Hospitalier Universitaire Vaudois
Class:
OTHER
Study ID:
CDR0000468827
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Prof Serge Leyvraz
Lead Sponsor Class:
OTHER
Responsible Party:
Prof Serge Leyvraz
Responsible Party Title:
Chef de Service
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Centre Hospitalier Universitaire Vaudois
Old Name:
None
Old Organization:
None